Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

publishing date : 2021 - 09 - 09    crawled time : 13:00    save search

Cryopreservation: A Key Element in the Successful Delivery of GMP Cell Therapies
Published: 2021-09-09 (Crawled : 13:00) - thermogenesis.com
THMO | $0.718 10.46% 9.47% 5.5K twitter stocktwits trandingview |
Health Technology
| | O: -0.84% H: 4.24% C: -2.12%

cryo liver therapy
REPAY Strengthens B2B Payments Team to Bolster Accelerating Growth in Accounts Payable (AP) and Accounts Receivable (AR) Automation
Published: 2021-09-09 (Crawled : 13:00) - repay.com
RPAY 4 | $10.065 3.55% 3.43% 510K twitter stocktwits trandingview |
Commercial Services
| | O: 0.13% H: 1.22% C: -1.13%
AAPL | $166.81 0.59% 0.58% 49M twitter stocktwits trandingview |
Electronic Technology
| | O: 0.24% H: 0.4% C: -0.91%

growth
Global Precipitated Calcium Carbonate Market Research Report (2021 to 2026) - by Type and Region
Published: 2021-09-09 (Crawled : 13:00) - prnewswire.com
USLM | $303.925 1.19% 1.17% 23K twitter stocktwits trandingview |
Non-Energy Minerals
| | O: -0.24% H: 0.79% C: -1.54%

research
Boron Nitride Cooling Fillers from 3M Used for Thermal Management in Advanced Polymers
Published: 2021-09-09 (Crawled : 13:00) - prnewswire.com
MMM | $93.0 0.41% -0.4% 3.7M twitter stocktwits trandingview |
Producer Manufacturing
| | O: -0.19% H: 0.52% C: -0.95%


Nabriva and Vizient Enter into Agreement to Make XENLETA® (lefamulin) Available to Vizient’s Pharmacy Network Program
Published: 2021-09-09 (Crawled : 13:00) - globenewswire.com
NBRV | $1.42 1.39% 720K twitter stocktwits trandingview |
Health Technology
| | O: 2.68% H: 0.87% C: -2.61%

lefamulin
The Off-Road Trail to 6 GHz AP Discovery
Published: 2021-09-09 (Crawled : 13:00) - extremenetworks.com
EXTR 4 | $11.08 3.26% 3.16% 1.3M twitter stocktwits trandingview |
Electronic Technology
| | O: 0.29% H: 2.24% C: 0.1%


Oramed to Present at H.C. Wainwright 23rd Annual Global Investment Conference
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
ORMP A | $2.39 2.58% 2.51% 31K twitter stocktwits trandingview |
Health Technology
| | O: -0.79% H: 8.26% C: 5.03%

conference
PDS Biotech Completes Enrollment of Lead-In Safety Cohort in VERSATILE-002 Phase 2 Combination Trial of PDS0101-KEYTRUDA® in Recurrent or Metastatic Head and Neck Cancer
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
PDSB | $3.2 7.02% 6.56% 990K twitter stocktwits trandingview |
Health Technology
| | O: 0.59% H: 6.23% C: 1.56%

phase 2 cancer biotech iot trial keytruda enroll
Cassava Sciences to Present at H.C. Wainwright’s 23rd Annual Global Investment Conference
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
SAVA M | $20.54 0.19% 0.19% 500K twitter stocktwits trandingview |
Health Technology
| | O: 1.11% H: 8.91% C: 5.78%

conference
Allena Pharmaceuticals to Participate in H.C. Wainwright’s 23rd Annual Global Investment Conference
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
ALNA | $0.075 -12.0% twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 2.91% C: 1.94%

conference
Aldeyra Therapeutics to Participate in the Virtual Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
ALDX | $3.91 -0.51% -0.51% 450K twitter stocktwits trandingview |
Health Technology
| | O: -0.11% H: 0.9% C: 0.0%

life science
Wave Life Sciences Announces Initiation of Dosing in Phase 1b/2a SELECT-HD Clinical Trial of WVE-003 in Huntington’s Disease
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
WVE | $5.085 5.06% 4.82% 470K twitter stocktwits trandingview |
Health Technology
| | O: 0.34% H: 4.48% C: 2.7%

huntington disease phase 1 life science trial phase 1b phase 2b huntington’s disease
Xenetic Biosciences, Inc. Receives Notice of Allowance for XCART(TM) Patent
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
XBIO | $3.76 7.32% 2.7K twitter stocktwits trandingview |
Health Technology
| | O: -1.14% H: 3.85% C: 1.15%

patent bioscience
Syros Announces First Patient Dosed in SELECT-AML-1 Trial of Tamibarotene in Combination with Venetoclax and Azacitidine in Newly Diagnosed Unfit AML
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
SYRS | $5.17 3.61% 3.48% 170K twitter stocktwits trandingview |
Health Technology
| | O: -0.76% H: 4.23% C: 1.54%

trial aml
Novan Announces Strategic Priorities and Outlines Key Milestones
Published: 2021-09-09 (Crawled : 13:00) - globenewswire.com
SYNH | $42.98 0.0% 7.4M twitter stocktwits trandingview |
Health Services
| | O: 0.17% H: 0.91% C: -0.21%
NOVN | $0.0941 -24.84% -32.91% 7.2M twitter stocktwits trandingview |
Health Technology
| | O: -6.59% H: 0.0% C: -4.42%

milestone
Cambridge Trust Commits $110 Million to Finance Affordable Housing Through the Massachusetts Housing Partnership
Published: 2021-09-09 (Crawled : 13:00) - prnewswire.com
CATC | $63.905 1.82% 1.79% 10K twitter stocktwits trandingview |
Finance
| | O: 0.0% H: 0.4% C: 0.0%

partnership ford
Emerging Teen Talent Sophie Pecora Wins Grand Prize in Unsigned Only Music Competition
Published: 2021-09-09 (Crawled : 13:00) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
| Email alert Add to watchlist


oVertone Announces Urban Outfitters as New National Retail Partner
Published: 2021-09-09 (Crawled : 13:00) - prnewswire.com
FNCTF | News | $11.16 -20.84% 130 twitter stocktwits trandingview |
Communications
| Email alert Add to watchlist


Oceania Cruises Unveils Inaugural Season Voyages For Vista
Published: 2021-09-09 (Crawled : 13:00) - prnewswire.com
NCLH | $19.54 5.39% -0.21% 10M twitter stocktwits trandingview |
Consumer Services
| | O: -0.25% H: 4.91% C: 2.38%
NCLH | $19.54 5.39% -0.21% 10M twitter stocktwits trandingview |
Consumer Services
| | O: -0.25% H: 4.91% C: 2.38%


FDA Grants Breakthrough Device Designation to the NovoTTF-200T™ System for Advanced Liver Cancer
Published: 2021-09-09 (Crawled : 13:00) - biospace.com/
NVCR | $12.055 1.9% 1.87% 750K twitter stocktwits trandingview |
Health Technology
| | O: 1.9% H: 3.69% C: 0.07%

fda cancer device liver granted grant designation
Gainers vs Losers
78% 22%

Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M twitter stocktwits trandingview |

AGBA | $2.94 135.2% 57.48% 66M twitter stocktwits trandingview |
Finance

EDBL | News | $6.46 71.81% 41.8% 2M twitter stocktwits trandingview |

MTC | $2.25 44.23% 30.67% 6M twitter stocktwits trandingview |
Technology Services

OPRT | News | $3.175 41.11% 29.13% 12M twitter stocktwits trandingview |
Finance

SHIM | $3.05 35.56% 26.23% 1.1M twitter stocktwits trandingview |

HKIT | $1.345 31.86% 24.16% 390K twitter stocktwits trandingview |
Technology Services

ABVC | $1.36 30.77% 23.53% 7.4M twitter stocktwits trandingview |
Wholesale Trade

OST | $0.512 28.0% 21.88% 290K twitter stocktwits trandingview |

POET | $1.59 27.2% 21.38% 4.2M twitter stocktwits trandingview |
Manufacturing


Your saved searches
Save your searches and get alerts when important news are released.